Trial Profile
Long term efficacy of Metreleptin and its effect of nocturnal luteinising hormone (LH) in patients with Lipodystrophy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Apr 2017
Price :
$35
*
At a glance
- Drugs Metreleptin (Primary)
- Indications Lipodystrophy
- Focus Therapeutic Use
- 19 Apr 2017 New trial record
- 04 Apr 2017 Results presented at The 99th Annual Meeting of the Endocrine Society